Explore
13D/13G Activist Filings
118,739 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | WLTH | Wealthfront Corporation | Tiger Global Private Investment Partners X, L.P. | 13G | 10.4% | 15.1M |
| Feb 17, 2026 | MYFW | First Western Financial, Inc. | North Reef Capital Management LP | 13G/A | 7.1% | 686K |
| Feb 17, 2026 | EGBN | Eagle Bancorp, Inc. | North Reef Capital Management LP | 13G/A | 9.7% | 2.9M |
| Feb 17, 2026 | STEL | Stellar Bancorp, Inc. | North Reef Capital Management LP | 13G | 5.6% | 2.9M |
| Feb 17, 2026 | PRGO | PERRIGO Co plc | Fuller & Thaler Asset Management, Inc. | 13G | 5.7% | 7.8M |
| Feb 17, 2026 | N/A | Private Bancorp of America, Inc. | Banc Fund IX L.P. | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | BIGC | Commerce.com, Inc. | Divisar Partners QP, L.P. | 13G/A | 4.3% | 3.5M |
| Feb 17, 2026 | DMAC | DiaMedica Therapeutics Inc. | Dialectic Life Sciences SPV LLC | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | ZVIA | Zevia PBC | Tallwoods Investments, LLC | 13G/A | 1.0% | 698K |
| Feb 17, 2026 | VYX | NCR Voyix Corp | Fuller & Thaler Asset Management, Inc. | 13G/A | 4.8% | 6.7M |
| Feb 17, 2026 | IBIO | iBio, Inc. | Lynx1 Capital Management LP | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | VAC | MARRIOTT VACATIONS WORLDWIDE Corp | Fuller & Thaler Asset Management, Inc. | 13G/A | 5.0% | 1.7M |
| Feb 17, 2026 | DTIL | PRECISION BIOSCIENCES INC | Lynx1 Capital Management LP | 13G/A | 4.1% | 994K |
| Feb 17, 2026 | GHRS | GH Research PLC | Lynx1 Capital Management LP | 13G/A | 16.8% | 10.4M |
| Feb 17, 2026 | CCCC | C4 Therapeutics, Inc. | Lynx1 Capital Management LP | 13G/A | 7.3% | 7.1M |
| Feb 17, 2026 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | Fuller & Thaler Asset Management, Inc. | 13G/A | 4.7% | 3.6M |
| Feb 17, 2026 | INDV | Indivior Pharmaceuticals, Inc. | Fuller & Thaler Asset Management, Inc. | 13G | 5.1% | 6.4M |
| Feb 17, 2026 | N/A | Oregon Pacific Bancorp | Banc Fund IX L.P. | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | HOPE | HOPE BANCORP INC | Fuller & Thaler Asset Management, Inc. | 13G/A | 4.7% | 6.1M |
| Feb 17, 2026 | LGHL | Lion Group Holding Ltd | Marex Financial | 13G | 7.8% | 35K |
| Feb 17, 2026 | AYTU | AYTU BIOPHARMA, INC | LYTTON LAURENCE W | 13G/A | 10.0% | 1.1M |
| Feb 17, 2026 | SLMT | Brera Holdings PLC | Qube Research & Technologies Ltd | 13G/A | 7.3% | 6.0M |
| Feb 17, 2026 | MTN | Vail Resorts, Inc. | Oasis Management Co Ltd. | 13G | 5.2% | 1.9M |
| Feb 17, 2026 | HI | Hillenbrand, Inc. | Fuller & Thaler Asset Management, Inc. | 13G/A | 0.0% | 1K |
| Feb 17, 2026 | SNAX | STRYVE FOODS, INC. | LYTTON LAURENCE W | 13G/A | 10.0% | 415K |
| Feb 17, 2026 | N/A | NAPC Defense, Inc. | Educational Group LLC | 13G/A | 8.6% | 0 |
| Feb 17, 2026 | GTX | Garrett Motion Inc. | Fuller & Thaler Asset Management, Inc. | 13G | 5.3% | 10.3M |
| Feb 17, 2026 | MMU | WESTERN ASSET MANAGED MUNICIPALS FUND INC. | RIVERNORTH CAPITAL MANAGEMENT, LLC | 13G/A | 5.0% | 2.7M |
| Feb 17, 2026 | FNB | FNB CORP/PA/ | Fuller & Thaler Asset Management, Inc. | 13G/A | 5.9% | 21.0M |
| Feb 17, 2026 | N/A | Scinai Immunotherapeutics Ltd. | STONE DANIEL E. | 13G/A | 9.9% | 347K |
| Feb 17, 2026 | COLD | AMERICOLD REALTY TRUST | Fuller & Thaler Asset Management, Inc. | 13G/A | 6.1% | 17.3M |
| Feb 17, 2026 | AAP | ADVANCE AUTO PARTS INC | Fuller & Thaler Asset Management, Inc. | 13G/A | 4.7% | 2.8M |
| Feb 17, 2026 | TLPH | TALPHERA, INC. | LYTTON LAURENCE W | 13G/A | 5.9% | 2.7M |
| Feb 17, 2026 | SONM | DNA X, Inc. | LYTTON LAURENCE W | 13G/A | 10.0% | 148K |
| Feb 17, 2026 | JBIO | JADE BIOSCIENCES, INC. | JANUS HENDERSON GROUP PLC | 13G | 6.2% | 3.1M |
| Feb 17, 2026 | XTNT | Xtant Medical Holdings, Inc. | LYTTON LAURENCE W | 13G/A | 5.5% | 7.7M |
| Feb 17, 2026 | CTNM | CONTINEUM THERAPEUTICS, INC. | JANUS HENDERSON GROUP PLC | 13G | 7.9% | 2.4M |
| Feb 17, 2026 | IMMX | IMMIX BIOPHARMA, INC. | JANUS HENDERSON GROUP PLC | 13G | 7.4% | 3.9M |
| Feb 17, 2026 | VRDN | Viridian Therapeutics, Inc. | Kynam Capital Management, LP | 13G/A | 1.5% | 1.5M |
| Feb 17, 2026 | N/A | MSD Investment Corp. | MSD Capital, L.P. | 13G/A | 24.0% | 33.0M |
| Feb 17, 2026 | ENGN | enGene Holdings Inc. | Kynam Capital Management, LP | 13G/A | 2.2% | 1.5M |
| Feb 17, 2026 | DKNG | DRAFTKINGS INC. | JANUS HENDERSON GROUP PLC | 13G | 5.1% | 25.3M |
| Feb 17, 2026 | GKOS | GLAUKOS CORP | JANUS HENDERSON GROUP PLC | 13G | 5.3% | 3.0M |
| Feb 17, 2026 | BBIO | BRIDGEBIO PHARMA, INC. | JANUS HENDERSON GROUP PLC | 13G | 5.7% | 11.0M |
| Feb 17, 2026 | COGT | Cogent Biosciences, Inc. | Kynam Capital Management, LP | 13G/A | 4.3% | 6.2M |
| Feb 17, 2026 | BELFB | BEL FUSE INC. | JANUS HENDERSON GROUP PLC | 13G | 5.9% | 619K |
| Feb 17, 2026 | SSEAU | STARRY SEA ACQUISITION CORP | Space Summit Capital LLC | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | PTCT | PTC THERAPEUTICS, INC. | JANUS HENDERSON GROUP PLC | 13G | 6.0% | 4.9M |
| Feb 17, 2026 | FDMT | 4D MOLECULAR THERAPEUTICS, INC. | JANUS HENDERSON GROUP PLC | 13G | 8.1% | 4.6M |
| Feb 17, 2026 | N/A | Newbridge Acquisition Ltd | Space Summit Capital LLC | 13G | 7.3% | 365K |